Sanguina, Inc.
PrivateLast Round
Grant
Sep 14, 2023
Total Funding Raised
$5.85M
Company Overview
Sanguina, Inc. operates in Healthcare & Life Sciences and is based in Peachtree Corners, Georgia. Its latest recorded funding round was a Grant round in September 2023.
Sanguina, Inc. is a healthtech company that provides point-of-care diagnostics products, including at-home tests and digital tools, for anemia screening and blood health management.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Telemedicine, Computer Vision
Business Model
B2C
Customer Profile
Subscription SaaS, Freemium, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sanguina, Inc. Comparables
Compare Sanguina, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Monere | 81% | |
| HemaChrome | 79% | |
| Masimo Corporation | 61% |
For institutional investors. Book with your work email.
Sanguina, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 14, 2023 | ||||
| Series A | Jul 25, 2023 | ||||
| Seed | Dec 8, 2020 | ||||
| Grant | Feb 26, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Sanguina, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| XRC Labs | Seed |
| The Seed Lab | Series A, Seed |
| Veritus Holdings | Series A |
| National Institutes of Health (NIH) | Grant |
| National Science Foundation | Grant |
| Veritus Holdings | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 31, 2025
Named Grand Prize Winner in the RADx Maternal Health Challenge.
- Sep 14, 2023
$525K grant received from the National Institutes of Health.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- integrates_withSep 23, 2026
On Sep 23rd '26, Sanguina plans to integrate its non-invasive fingernail-analysis tools for remote blood health screening into QC Healthcare's virtual care network in the United States, initially supporting My Pediatric Doctor and My Adult Doctor's 24/7 urgent and primary care services.
For institutional investors. Book with your work email.
Sanguina, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sanguina, Inc.'s valuation, stock price, and market status.
Is Sanguina, Inc. a public or private company?
Sanguina, Inc. is a private company.
What is the current stock price of Sanguina, Inc.?
Sanguina, Inc. is a private company, so its shares have no public market price. Caplight tracks Sanguina, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sanguina, Inc. worth (valuation)?
Valuation information for Sanguina, Inc. is not publicly available.
Can I buy Sanguina, Inc. stock?
Sanguina, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sanguina, Inc.'s last funding round?
Sanguina, Inc.'s most recent funding round was Grant on September 14, 2023.
Who are the main investors in Sanguina, Inc.?
Key investors in Sanguina, Inc. include Veritus Holdings, Veritus Holdings.
Will Sanguina, Inc. IPO soon?
No public IPO plans have been announced for Sanguina, Inc..
How can I track Sanguina, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Sanguina, Inc.'s shares on secondary markets.